Picture of Corline Biomedical AB logo

CLBIO — Corline Biomedical AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Brief: Corline Biomedical Enters Term Sheet Regarding Additional Medical Applications In USA

Aug 2 (Reuters) - Corline Biomedical AB  CLBIO.ST :
    * ENTERS INTO TERM SHEET REGARDING ADDITIONAL MEDICAL
APPLICATIONS
IN USA
    * COMMON GOAL IS FOR CUSTOMER AND CORLINE TO TRANSFORM TERM
SHEET
INTO A BINDING AGREEMENT DURING Q3 2021
    * AFTER COMPLETED DEVELOPMENT AND UPSCALING PERIOD, THE
APPLICATION  IS EXPECTED TO BE ABLE TO GENERATE REVENUE FOR
CORLINE OF MORE THAN SEK 50 MLN ANNUALLY

Source text for Eikon:  ID:nGNE4V8rKc 
Further company coverage:  CLBIO.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on Corline Biomedical AB

See all news